However, the survival analyses indicated that FSTL1 is not a significant prognosis factor for CRC and FSTL1 protein expression had no significant association with any clinic-pathological features in colon cancer patients, such as tumor size, grade, sex and phase [17]. Here, FSTL1 is linked to colorectal carcinoma.